Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,493 papers from all fields of science
Search
Sign In
Create Free Account
Alpha Fetoprotein L1 Measurement
Known as:
AFPL1
, Alpha Fetoprotein L1
The determination of the amount of alpha fetoprotein L1 present in a sample.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
N. Fraleigh
,
Reynaldo Oliva
,
+4 authors
Hoang-Thanh Le
PLoS ONE
2019
Corpus ID: 201630825
Despite the increased risks of cancers and cardiovascular related diseases, tobacco smoking continues to be prevalent in the…
Expand
2016
2016
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
N. Fraleigh
,
Justin Boudreau
,
+7 authors
Hoang-Thanh Le
Heliyon
2016
Corpus ID: 16345883
2014
2014
Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.
B. Romeu
,
M. Lastre
,
+6 authors
O. Pérez
Vaccine
2014
Corpus ID: 34892427
2009
2009
Intranasal immunization with AFCo1 induce systemic, mucosal and memory immune response in neonatal mice
J. Balboa
,
B. Romeu
,
+7 authors
Oliver Pére
2009
Corpus ID: 54507900
Neonates have a poorly developed immune system. Respiratory pathogens cause disease during early periods of live. Consequently…
Expand
2009
2009
Mucosal immune response induced by proteoliposome and cochleate derived from serogroups B N. meningitidis
J. Campo
,
M. Lastre
,
+8 authors
O. Pérez
2009
Corpus ID: 56217000
Mucosal vaccination offers attractive advantages to conventional systemic vaccination. Most pathogens enter or establish…
Expand
2009
2009
C-3 : STUDY OF NEISSERIA MENINGITIDIS OMV USING PROTEOMIC TECHNIQUES
L. Betancourt
,
J. Valdés
,
+12 authors
M. Christodoulides
2009
Corpus ID: 53374504
VacciMonitor 2009; Vol. 18 No. 2 Background and Aims. Meningococcal B strains accounts for some 72% and 28% of meningococcal…
Expand
Highly Cited
2007
Highly Cited
2007
New Vaccines Require Potent Adjuvants like AFPL1 and AFCo1
O. Pérez
,
M. Lastre
,
+16 authors
C. Campa
Scandinavian Journal of Immunology
2007
Corpus ID: 27122253
Neisseria meningitidis B proteoliposome (AFPL1 when used as adjuvant) and its derivative‐Cochleate (AFCo1) contain…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE